Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Autism biomarker study seeks better ways to measure social function

NCT ID NCT05294705

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 24 times

Summary

This study aims to confirm whether certain brain and eye-tracking measures can serve as reliable biomarkers for autism. Researchers will compare 200 children with autism and 200 typically developing children, aged 6-11, using EEG and gaze tracking. The goal is to provide better tools for future clinical trials, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02445, United States

  • Children's Hospital Los Angeles

    Los Angeles, California, 90027, United States

  • Duke

    Durham, North Carolina, 27708, United States

  • Unviersity of Washington

    Seattle, Washington, 98105, United States

  • Yale Child Study Center

    New Haven, Connecticut, 06519, United States

Conditions

Explore the condition pages connected to this study.